| WKY |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 63 days) |
Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81. |
arterial blood pressure trait |
male |
91.0 days
| 4 |
|
serial mean |
131.7 |
mmHg |
2.25 |
4.5 |
tail cuff photoplethysmography |
|
0 |
|
|
|
UR1000; Ueda |
average of 3 consistent readings |
12584 |
268 |
| WKY |
systolic blood pressure |
puromycin aminonucleoside (50 mg/kg) (for 70 days) then saralasin (0.3 mg/kg/hr) (for 0.5 hours) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
arterial blood pressure trait |
male |
days
| 5 |
|
|
118.0 |
mmHg |
4.0 |
8.94 |
tail cuff plethysmography |
|
0.0 |
PA IV 50mg/kg |
70 |
days |
|
|
100593 |
2479 |
| WKY |
systolic blood pressure |
0.9% sodium chloride solution (50 mg/kg) (for 0.5 hours) then 0.9% sodium chloride solution |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
arterial blood pressure trait |
male |
days
| 5 |
|
|
131.0 |
mmHg |
4.0 |
8.94 |
tail cuff plethysmography |
|
0.0 |
PA IV 50mg/kg |
|
|
|
|
100595 |
2479 |
| WKY |
systolic blood pressure |
controlled enalapril content drinking water (50 mg/l) (for 22 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
arterial blood pressure trait |
male |
days
| 5 |
|
|
95.0 |
mmHg |
9.0 |
20.12 |
tail cuff plethysmography |
|
0.0 |
PA IV 50mg/kg |
15 |
days |
|
|
100447 |
2479 |
| WKY |
systolic blood pressure |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
arterial blood pressure trait |
male |
days
| 9 |
|
|
108.0 |
mmHg |
3.0 |
9.0 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
100451 |
2479 |
| WKY |
systolic blood pressure |
sham surgical control condition (for 224 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
arterial blood pressure trait |
male |
266.0 days-280.0 days |
5 |
10 min mean |
continuous mean |
97.8 |
mmHg |
6.3 |
14.09 |
vascular transducer tipped catheter |
|
0.0 |
lad occlusion sham |
210 |
days |
|
|
100315 |
2460 |
| WKY |
systolic blood pressure |
diclofenac (10 mg/kg) (for 1 hours) |
Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9. |
arterial blood pressure trait |
male |
90.0 days-120.0 days |
7 |
|
|
123.7 |
mmHg |
1.06 |
2.8 |
tail cuff plethysmography |
|
|
|
60 |
min |
IP |
|
108359 |
3101 |
| WKY |
systolic blood pressure |
control condition |
Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19. |
arterial blood pressure trait |
male |
420.0 days
| 4 |
|
|
136.0 |
mmHg |
2.5 |
5.0 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
109530 |
3147 |
| WKY |
systolic blood pressure |
controlled in utero environment (30 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
arterial blood pressure trait |
male |
112.0 days
| 6 |
undefined |
|
125.0 |
mmHg |
2.0 |
4.9 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
101684 |
2218 |
| WKY |
systolic blood pressure |
control condition (for 280 days) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
arterial blood pressure trait |
male |
280.0 days
| 9 |
undefined |
|
130.0 |
mmHg |
2.33 |
7.0 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
100232 |
2459 |
| WKY |
systolic blood pressure |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
arterial blood pressure trait |
male |
days
| 5 |
|
|
127.0 |
mmHg |
5.0 |
11.18 |
tail cuff plethysmography |
|
0.0 |
PA IV 50mg/kg |
|
|
|
|
100594 |
2479 |
| WKY |
systolic blood pressure |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
arterial blood pressure trait |
male |
266.0 days-280.0 days |
16 |
10 min mean |
continuous mean |
79.5 |
mmHg |
5.1 |
20.4 |
vascular transducer tipped catheter |
|
0.0 |
lad occlusion |
210 |
days |
|
|
100316 |
2460 |
| WKY |
systolic blood pressure |
control condition |
Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46 |
arterial blood pressure trait |
male |
175.0 days
| 24 |
|
continuous mean |
167.3 |
mmHg |
2.37 |
11.6 |
vascular indwelling catheter method |
aorta |
|
|
|
|
|
|
11901 |
206 |
| WKY |
systolic blood pressure |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
arterial blood pressure trait |
male |
days
| 9 |
|
|
106.0 |
mmHg |
3.0 |
9.0 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
100445 |
2479 |
| WKY |
systolic blood pressure |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
arterial blood pressure trait |
male |
days
| 7 |
|
|
112.0 |
mmHg |
5.0 |
13.23 |
tail cuff plethysmography |
|
0.0 |
PA IV 50mg/kg |
15 |
days |
|
|
100446 |
2479 |
| WKY |
systolic blood pressure |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
arterial blood pressure trait |
male |
days
| 8 |
|
|
113.0 |
mmHg |
4.0 |
11.31 |
tail cuff plethysmography |
|
0.0 |
PA IV 50mg/kg |
490 |
days |
|
|
100452 |
2479 |
| WKY |
systolic blood pressure |
control condition |
Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9. |
arterial blood pressure trait |
male |
90.0 days-120.0 days |
7 |
|
|
125.3 |
mmHg |
0.68 |
1.8 |
tail cuff plethysmography |
|
|
|
|
|
|
|
108357 |
3101 |
| WKY |
systolic blood pressure |
control condition (for 0 hours) |
Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1. |
arterial blood pressure trait |
male |
84.0 days
| 5 |
|
|
125.0 |
mmHg |
2.0 |
4.47 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
103470 |
2826 |
| WKY |
systolic blood pressure |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
arterial blood pressure trait |
male |
days
| 9 |
|
|
121.0 |
mmHg |
2.0 |
6.0 |
tail cuff plethysmography |
|
0.0 |
PA IV 50mg/kg |
|
|
|
|
100449 |
2479 |
| WKY |
systolic blood pressure |
control condition |
Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9. |
arterial blood pressure trait |
male |
90.0 days-120.0 days |
7 |
|
|
123.4 |
mmHg |
0.76 |
2.0 |
tail cuff plethysmography |
|
|
|
|
|
|
|
108365 |
3101 |
| WKY |
systolic blood pressure |
diclofenac (40 mg/kg) (for 1 hours) |
Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9. |
arterial blood pressure trait |
male |
90.0 days-120.0 days |
7 |
|
|
122.9 |
mmHg |
0.79 |
2.1 |
tail cuff plethysmography |
|
|
|
60 |
min |
0.1% methylcellulose per os |
|
108367 |
3101 |
| WKY |
systolic blood pressure |
control condition |
Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19. |
arterial blood pressure trait |
male |
350.0 days
| 4 |
|
|
124.0 |
mmHg |
3.5 |
7.0 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
109529 |
3147 |
| WKY |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 63 days) |
Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81. |
arterial blood pressure trait |
female |
91.0 days
| 4 |
|
serial mean |
127.0 |
mmHg |
5.75 |
11.5 |
tail cuff photoplethysmography |
|
0 |
|
|
|
UR1000; Ueda |
average of 3 consistent readings |
12585 |
268 |
| WKY |
systolic blood pressure |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
arterial blood pressure trait |
male |
days
| 5 |
|
|
119.0 |
mmHg |
3.0 |
6.71 |
tail cuff plethysmography |
|
0.0 |
PA IV 50mg/kg |
|
|
|
|
100592 |
2479 |
| WKY |
systolic blood pressure |
controlled in utero environment (100 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
arterial blood pressure trait |
male |
112.0 days
| 5 |
undefined |
|
104.0 |
mmHg |
2.0 |
4.47 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
101683 |
2218 |
| WKY |
systolic blood pressure |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
arterial blood pressure trait |
male |
days
| 8 |
|
|
117.0 |
mmHg |
2.0 |
5.66 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
100448 |
2479 |
| WKY |
systolic blood pressure |
controlled enalapril content drinking water (50 mg/l) (between 63 and 77 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
arterial blood pressure trait |
male |
days
| 8 |
|
|
100.0 |
mmHg |
1.0 |
2.83 |
tail cuff plethysmography |
|
0.0 |
PA IV 50mg/kg |
|
|
|
|
100450 |
2479 |
| WKY |
systolic blood pressure |
controlled enalapril content drinking water (50 mg/l) (for 497 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
arterial blood pressure trait |
male |
days
| 9 |
|
|
96.0 |
mmHg |
2.0 |
6.0 |
tail cuff plethysmography |
|
0.0 |
PA IV 50mg/kg |
490 |
days |
|
|
100453 |
2479 |
| WKY |
systolic blood pressure |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
arterial blood pressure trait |
male |
266.0 days-280.0 days |
32 |
10 min mean |
continuous mean |
75.1 |
mmHg |
2.4 |
13.58 |
vascular transducer tipped catheter |
|
0.0 |
lad occlusion |
210 |
days |
|
|
100317 |
2460 |
| WKY |
systolic blood pressure |
control condition |
Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9. |
arterial blood pressure trait |
male |
90.0 days-120.0 days |
7 |
|
|
122.8 |
mmHg |
0.6 |
1.6 |
tail cuff plethysmography |
|
|
|
|
|
|
|
108361 |
3101 |
| WKY |
systolic blood pressure |
diclofenac (20 mg/kg) (for 1 hours) |
Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9. |
arterial blood pressure trait |
male |
90.0 days-120.0 days |
7 |
|
|
122.6 |
mmHg |
0.74 |
1.97 |
tail cuff plethysmography |
|
|
|
60 |
min |
0.1% methylcellulose per os |
|
108363 |
3101 |
| WKY |
systolic blood pressure |
control condition |
Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19. |
arterial blood pressure trait |
male |
280.0 days
| 4 |
|
|
135.0 |
mmHg |
3.5 |
7.0 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
109528 |
3147 |